Is Orkambi deal close? Vertex meets again today with NHS England

21 March 2019 - Campaigners hopes rise after three year wait. ...

Read more →

Unprecedented drug shortage linked to Brexit, NHS bosses say

20 March 2019 - Hospitals across England are experiencing medicine shortages due to "stockpiling and price pressure as the Brexit ...

Read more →

Biosimilar groups offer proposals to help US better mirror EU successes

19 March 2019 - With 18 biosimilars approved in the US and just seven on the market, two biosimilars groups ...

Read more →

Biosimilar approval and adoption in the U.S. needs to be expedited

20 March 2019 - Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. ...

Read more →

Where is the champion for Pharmacare?

20 March 2019 - With the possible exception of a few drug company executives, Canadians overwhelmingly support universal pharmacare — ...

Read more →

National drug agency touted as building block of Pharmacare plan

19 March 2019 - The Trudeau Liberals’ new budget promises a new agency to buy drugs in bulk and cut ...

Read more →

Senate bill endorses Azar's call to allow drug imports

20 March 2019 - Bipartisan support for a Senate bill that seeks to allow drug importation to boost competition dovetails ...

Read more →

Iterum Therapeutics receives QIDP for oral and IV sulopenem in four additional indications as well as fast track designation

19 March 2019 - New designations in community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory disease demonstrate the ...

Read more →

Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control, as well as for CV risk reduction for oral semaglutide and Ozempic

20 March 2019 - Novo Nordisk today announced the submission of two new drug applications to the US FDA for ...

Read more →

FDA reform: it’s time to act, but not as an independent agency

19 March 2019 - In a rare exercise in bipartisan leadership, former FDA commissioners of both political parties called, in ...

Read more →

The shadow of Brexit on speed of access

20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union.  ...

Read more →

Partisan squabbles shadow Congress' efforts to lower drug prices

20 March 2019 - It was supposed to be one of the few areas of bipartisanship. ...

Read more →

Cancer Society slams PHARMAC's treatment of patients

20 March 2019 - The Cancer Society says New Zealand patients are worse off than those in Australia. ...

Read more →

Roche and the pan-Canadian Pharmaceutical Alliance complete negotiations for multiple sclerosis treatment, Ocrevus (ocrelizumab), for both RRMS and PPMS

19 March 2019 - Roche Canada today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for a ...

Read more →

Canada to create national drug agency to help cut cost of medicines

20 March 2019 - Canada will create a national drug agency to help cut the cost of prescription medications as part ...

Read more →

FDA approves first treatment for post-partum depression

19 March 2019 - The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous use for the treatment ...

Read more →